Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4C | Q9H3R0 | 11/20 | 0.55 |
| ▸ | KDM6B | O15054 | 5/20 | 0.55 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.55 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.55 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.55 |
| ▸ | KDM4D | Q6B0I6 | 3/20 | 0.55 |
| ▸ | KDM4A | O75164 | 2/20 | 0.55 |
| ▸ | MEN1 | O00255 | 2/20 | 0.55 |
| ▸ | THRB | P10828 | 2/20 | 0.55 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.55 |
| ▸ | MAPT | P10636 | 1/20 | 0.55 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.55 |
| ▸ | CA1 | P00915 | 3/20 | 0.48 |
| ▸ | CA2 | P00918 | 3/20 | 0.48 |
| ▸ | CA12 | O43570 | 2/20 | 0.48 |
| ▸ | CA7 | P43166 | 2/20 | 0.48 |
| ▸ | CA9 | Q16790 | 2/20 | 0.48 |
| ▸ | CA14 | Q9ULX7 | 2/20 | 0.48 |
| ▸ | NAPRT | Q6XQN6 | 2/20 | 0.48 |
| ▸ | HPGD | P15428 | 2/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30804202 | 1.00 | KDM4C (0.55) | KDM4CKDM6BALDH1A1KDM4ETDP1 | |
| SCHEMBL4768904 | 0.98 | KDM4C (0.53) | KDM4CKDM6BALDH1A1KDM4ETDP1 | |
| SCHEMBL11819131 | 0.89 | KDM4C (0.46) | KDM4CKDM6BALDH1A1KDM4ETDP1 | |
| SCHEMBL27711603 | 0.84 | KDM4C (0.42) | KDM4CKDM6BALDH1A1KDM4ETDP1 | |
| SCHEMBL2562774 | 0.82 | KDM4C (0.61) | KDM4CKDM6BALDH1A1KDM4ETDP1 | |
| SCHEMBL29822292 | 0.82 | KDM4C (0.61) | KDM4CKDM6BALDH1A1KDM4ETDP1 | |
| SCHEMBL29416303 | 0.81 | KDM4C (0.65) | KDM4CKDM6BALDH1A1KDM4ETDP1 | |
| SCHEMBL71335 | 0.81 | KDM4C (0.65) | KDM4CKDM6BALDH1A1KDM4ETDP1 | |
| SCHEMBL18163749 | 0.81 | KDM4E (0.53) | KDM4CALDH1A1KDM4ETDP1MEN1 | |
| SCHEMBL19838598 | 0.80 | TDP1 (0.47) | KDM4CKDM6BALDH1A1KDM4ETDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 339 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12077680-B2 | Polishing composition, production method of the same, polishing method and a manufacturing method of a semiconductor substrate | FUJIMI INCORPORATED (JP) | 2024-09-03 | — | — | US | claimed |
| CN-110759860-B | Preparation method of 3-methyl formate-4-methoxy-5-cyanopyridine | 江苏瑞科医药科技有限公司 | 2022-10-14 | — | — | CN | claimed |
| US-20210301174-A1 | POLISHING COMPOSITION, PRODUCTION METHOD OF THE SAME, POLISHING METHOD AND A MANUFACTURING METHOD OF A SEMICONDUCTOR SUBSTRATE | FUJIMI INCORPORATED (JP) | 2021-09-30 | — | — | US | claimed |
| CN-110759860-A | Preparation method of 3-methyl formate-4-methoxy-5-cyanopyridine | 江苏瑞科医药科技有限公司 | 2020-02-07 | — | — | CN | claimed |
| US-9901663-B2 | Hollow stent filled with a therapeutic agent formulation | ABBOTT CARDIOVASCULAR SYSTEMS INC. (US) | 2018-02-27 | — | — | US | claimed |
| US-20170281653-A1 | DERMOCOSMETIC OR PHARMACEUTICAL USE OF A COMPOSITION CONTAINING AT LEAST ONE INHIBITOR OF CERTAIN CHEMOKINES | GREENPHARMA SAS (FR) | 2017-10-05 | — | — | US | claimed |
| EP-2994174-A1 | A HOLLOW STENT FILLED WITH A THERAPEUTIC AGENT FORMULATION | Abbott Cardiovascular Systems Inc. (US) | 2016-03-16 | — | — | EP | claimed |
| CN-105188791-A | Hollow stent filled with therapeutic agent formulation | ABBOTT CARDIOVASCULAR SYSTEMS | 2015-12-23 | — | — | CN | claimed |
| WO-2014182542-A1 | A HOLLOW STENT FILLED WITH A THERAPEUTIC AGENT FORMULATION | ABBOTT CARDIOVASCULAR SYSTEMS INC. (US) | 2014-11-13 | — | — | WO | claimed |
| US-20140330365-A1 | Hollow Stent Filled With A Therapeutic Agent Formulation | ABBOTT CARDIOVASCULAR SYSTEMS INC. | 2014-11-06 | — | — | US | claimed |
| EP-1183327-A1 | METAL CHELATING FILTERS AND METAL CHELATE FILTERS | Panbio Ltd. (AU) | 2002-03-06 | — | — | EP | claimed |
| WO-2000070012-A1 | METAL CHELATING FILTERS AND METAL CHELATE FILTERS | PANBIO LTD (AU) | 2000-11-23 | — | — | WO | claimed |
| US-5430049-A | Treating hyperproliferative disorders | GAUT ZANE N (US) | 1995-07-04 | — | — | US | claimed |
| EP-0064378-B1 | AFFINITY CHROMATOGRAPHY USING METAL IONS | The Public Health Laboratory Service Board (GB) | 1987-02-11 | — | — | EP | claimed |
| US-4431546-A | SEPARATION OF BIOLOGICAL MATERIAL IN A SOLUTION CONTAINING A METAL SALT USING A MATRIX-DYE LIGAND | THE PUBLIC HEALTH LABORATORY SERVICES BOARD (GB) | 1984-02-14 | — | — | US | claimed |
| EP-0064378-A2 | Affinity chromatography using metal ions | The Public Health Laboratory Service Board (GB) | 1982-11-10 | — | — | EP | claimed |
| JP-63105027-A | — | — | None | — | — | JP | disclosed |
| JP-9148195-A | — | — | None | — | — | JP | disclosed |
| US-3945995-A | ANTIBIOTICS, PENICILLIN | SUMITOMO CHEMICAL COMPANY, LIMITED (JA) | 1976-03-23 | — | — | US | disclosed |
| US-3939150-A | ALPHA-(4-OXO-4H-THIOPYRAN-3-CARBOXAMIDO)-P-HYDROXYBENZYL -PENICILLIN OR SALTS, BACTERICIDE | YAMANOUCHI PHARMACEUTICAL CO., LTD. (JA) | 1976-02-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170281653-A1 | DERMOCOSMETIC OR PHARMACEUTICAL USE OF A COMPOSITION CONTAINING AT LEAST ONE INHIBITOR OF CERTAIN CHEMOKINES | CCL2, CCL11, CCL5 | KDM4C 4324/4885KDM6B 3517/4885ALDH1A1 1163/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.